• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

豚鼠离体心脏组织中功能性β-2肾上腺素能受体介导的变时反应:强效β-2肾上腺素能受体激动剂TA 2005的选择性

A functional beta-2 adrenoceptor-mediated chronotropic response in isolated guinea pig heart tissue: selectivity of the potent beta-2 adrenoceptor agonist TA 2005.

作者信息

Voss H P, Shukrula S, Wu T S, Donnell D, Bast A

机构信息

Department of Pharmacochemistry, Leiden/Amsterdam Center for Drug Research, The Netherlands.

出版信息

J Pharmacol Exp Ther. 1994 Oct;271(1):386-9.

PMID:7965739
Abstract

Responses were measured of the highly potent beta-2 adrenoceptor agonist TA 2005, a new bronchodilator, on isolated guinea pig right and left atria and papillary muscle. The main objectives of the study were to investigate the selectivity of the compound and to determine whether guinea pig isolated heart tissues could be used as a model for investigating mechanisms of clinical cardiac side effects. It was found that the inotropic responses in all tissues were mediated by the beta-1 adrenoceptor only. TA 2005 was a partial agonist for the inotropic response compared with I-isoprenaline. For the right atrial chronotropic response, however, TA 2005 exerted a biphasic effect and reached 84% of the I-isoprenaline response. The first phase was mediated by the beta-2 adrenoceptor, whereas the second phase was beta-1 adrenoceptor mediated. Approximately 64% of the TA 2005 chronotropic response was exerted via the beta-2 adrenoceptor. Addition of the beta-2-selective antagonist ICI 188.551 blocked the beta-2 adrenoceptor-mediated response, providing only a monophasic response. Addition of the beta-1-selective antagonist ICI 89.406 resulted in further separation of the phases. The finding that a beta-2-mediated chronotropic response exists on the right atrium of the guinea pig sheds new light on selectivity studies. It is suggested that quantification of beta-1/beta-2 selectivity of beta adrenoceptor agonists be performed not on the basis of measurement of guinea pig right atrial chronotropism but rather on the basis of measurement of guinea pig left atrial inotropism.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对新型支气管扩张剂、高效β2肾上腺素能受体激动剂TA 2005作用于豚鼠离体左右心房及乳头肌的反应进行了测定。本研究的主要目的是调查该化合物的选择性,并确定豚鼠离体心脏组织是否可作为研究临床心脏副作用机制的模型。结果发现,所有组织中的变力反应仅由β1肾上腺素能受体介导。与异丙肾上腺素相比,TA 2005是变力反应的部分激动剂。然而,对于右心房变时反应,TA 2005发挥双相作用,达到异丙肾上腺素反应的84%。第一相由β2肾上腺素能受体介导,而第二相由β1肾上腺素能受体介导。TA 2005变时反应中约64%是通过β2肾上腺素能受体发挥作用的。添加β2选择性拮抗剂ICI 188.551可阻断β2肾上腺素能受体介导的反应,仅产生单相反应。添加β1选择性拮抗剂ICI 89.406可使各相进一步分离。豚鼠右心房存在β2介导的变时反应这一发现为选择性研究提供了新的线索。建议对β肾上腺素能受体激动剂β1/β2选择性的量化不应基于豚鼠右心房变时性的测量,而应基于豚鼠左心房变力性的测量。(摘要截短于250字)

相似文献

1
A functional beta-2 adrenoceptor-mediated chronotropic response in isolated guinea pig heart tissue: selectivity of the potent beta-2 adrenoceptor agonist TA 2005.豚鼠离体心脏组织中功能性β-2肾上腺素能受体介导的变时反应:强效β-2肾上腺素能受体激动剂TA 2005的选择性
J Pharmacol Exp Ther. 1994 Oct;271(1):386-9.
2
ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
J Pharmacol Exp Ther. 1989 Jan;248(1):240-8.
3
Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.新型海绵衍生支气管扩张剂S1319在离体豚鼠组织中的气管舒张作用及β2肾上腺素能受体选择性
Br J Pharmacol. 1999 Oct;128(3):716-20. doi: 10.1038/sj.bjp.0702839.
4
Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.新开发的支气管扩张剂TA - 2005对豚鼠离体组织的气管舒张作用及β2选择性
Jpn J Pharmacol. 1991 Oct;57(2):175-85. doi: 10.1254/jjp.57.175.
5
Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria.人类、大鼠、豚鼠和兔心房中的β-肾上腺素能受体亚型。
J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1216-21.
6
Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.β-肾上腺素能受体介导的对豚鼠前列腺中α1-肾上腺素能受体介导的和场刺激诱导的收缩反应的抑制作用。
Br J Pharmacol. 1997 Nov;122(6):1067-74. doi: 10.1038/sj.bjp.0701494.
7
Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.(-)-RO363 对人心脏β-肾上腺素能受体亚型、人克隆β3-肾上腺素能受体及啮齿动物肠道β3-肾上腺素能受体的作用。
Br J Pharmacol. 1997 Jan;120(2):165-76. doi: 10.1038/sj.bjp.0700850.
8
Comparison of the positive chronotropic response to 5-hydroxytryptamine with beta-adrenoceptor agonists on the guinea pig atria in vitro.豚鼠离体心房对5-羟色胺与β-肾上腺素能受体激动剂正性变时反应的比较。
J Cardiovasc Pharmacol. 1989 Jan;13(1):45-51.
9
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.5-[(R)-2-(5,6-二乙基茚满-2-基氨基)-1-羟乙基]-8-羟基-1H-喹啉-2-酮(茚达特罗)的体外和体内药理学特性,一种作用持续时间达24小时的新型吸入型β₂肾上腺素能受体激动剂
J Pharmacol Exp Ther. 2006 May;317(2):762-70. doi: 10.1124/jpet.105.098251. Epub 2006 Jan 24.
10
The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations.OPC - 2009对豚鼠离体气管、右心房和左心房标本的β - 肾上腺素能受体刺激特性。
Br J Pharmacol. 1977 Dec;61(4):513-21. doi: 10.1111/j.1476-5381.1977.tb07543.x.

引用本文的文献

1
Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中的超长效β受体激动剂
J Exp Pharmacol. 2020 Dec 14;12:589-602. doi: 10.2147/JEP.S259328. eCollection 2020.
2
Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review.噻托溴铵与新型长效β2 受体激动剂在稳定期 COPD 患者中的作用:综述。
Int J Chron Obstruct Pulmon Dis. 2013;8:425-32. doi: 10.2147/COPD.S49179. Epub 2013 Sep 18.
3
Increased response to β₂-adrenoreceptor stimulation augments inhibition of IKr in heart failure ventricular myocytes.
β₂-肾上腺素受体刺激反应增强可增强心力衰竭心室肌细胞中 IKr 的抑制。
PLoS One. 2012;7(9):e46186. doi: 10.1371/journal.pone.0046186. Epub 2012 Sep 28.
4
β(2) -adrenoceptor agonists: current and future direction.β2-肾上腺素受体激动剂:现状与未来方向。
Br J Pharmacol. 2011 May;163(1):4-17. doi: 10.1111/j.1476-5381.2011.01216.x.
5
ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?超长效β2肾上腺素能受体激动剂:哮喘和慢性阻塞性肺疾病的一种新兴治疗选择?
Drugs. 2007;67(4):503-15. doi: 10.2165/00003495-200767040-00002.
6
Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.新型海绵衍生支气管扩张剂S1319在离体豚鼠组织中的气管舒张作用及β2肾上腺素能受体选择性
Br J Pharmacol. 1999 Oct;128(3):716-20. doi: 10.1038/sj.bjp.0702839.